Haemostatic defects in cyanotic congenital heart disease.
Open Access
- 1 January 1979
- Vol. 41 (1) , 23-27
- https://doi.org/10.1136/hrt.41.1.23
Abstract
An investigation of defects of the haemostatic mechanism in 41 children with cyanotic congenital heart disease concluded that such abnormalities were common and normally involved factors synthesised in the liver, that is the vitamin K dependent factors (rothrombin, factors VII and IX) and factor V. No evidence was found of activation of the coagulation or fibrinolytic systems. The defects can be explained by deficient synthesis resulting from systemic hypoxia as well as from sluggishness of the local microcirculation caused by high blood viscosity. Vitamin K parenterally had no demonstrable effect. Replacement of these factors, possibly combined with measures to improve the microcirculation, therefore, appears to be the appropriate treatment.This publication has 52 references indexed in Scilit:
- FACTOR VIII ACTIVITY AND ANTIGEN IN SICK NEWBORNS WITH PATHOLOGICAL PROTEOLYSIS IN BLOODActa Paediatrica, 1978
- Shortened platelet survival in cyanotic heart diseaseThe Journal of Pediatrics, 1975
- Immunologic Studies in Haemophilia AScandinavian Journal of Haematology, 1973
- Polycythemia in cyanotic heart disease—a study of altered coagulationThe Journal of Pediatrics, 1970
- Hemostasis in cyanotic congenital heart diseaseThe Journal of Pediatrics, 1970
- Hyperviscosity in congenital heart diseaseThe Journal of Pediatrics, 1970
- Demonstration of Low Content of Fibrinolytic Inhibitors in Individuals with High Fibrinolytic CapacityScandinavian Journal of Clinical and Laboratory Investigation, 1970
- ABSENCE OF COAGULATION ABNORMALITIES IN CHILDREN WITH CYANOTIC CONGENITAL HEART-DISEASEThe Lancet, 1968
- HEPARIN TREATMENT OF HÆMORRHAGIC DIATHESIS IN CYANOTIC CONGENITAL HEART-DISEASEThe Lancet, 1967
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957